SCHEMBL3579340

SCHEMBL3579340

OCc1cc2ccc(F)cc2nc1Cl

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.62
KDM4E B2RXH2 3/20 0.62
KMT2A Q03164 4/20 0.47
NPSR1 Q6W5P4 1/20 0.47
GFER P55789 1/20 0.44
BACE1 P56817 1/20 0.38
GAA P10253 1/20 0.36
PDGFRB P09619 1/20 0.34
PDGFRA P16234 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
ALOX5 P09917 1/20 0.34
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAPT P10636 2/20 0.33
POLB P06746 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2A6 P11509 1/20 0.32
TBXA2R P21731 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4441765 0.88 ALDH1A1 (0.50) ALDH1A1KDM4EKMT2ANPSR1GFER
SCHEMBL1879421 0.88 KDM4E (0.49) ALDH1A1KDM4EKMT2ANPSR1GFER
SCHEMBL3578871 0.86 KMT2A (0.65) ALDH1A1KDM4EKMT2ANPSR1GFER
SCHEMBL14047370 0.84 KMT2A (0.50) ALDH1A1KDM4EKMT2ANPSR1GFER
SCHEMBL15449064 0.81 ALDH1A1 (0.60) ALDH1A1KDM4EKMT2ANPSR1GFER
SCHEMBL8644046 0.81 KMT2A (0.73) ALDH1A1KDM4EKMT2ANPSR1GFER
SCHEMBL30908421 0.81 KMT2A (0.73) ALDH1A1KDM4EKMT2ANPSR1GFER
SCHEMBL15321070 0.80 KMT2A (0.43) ALDH1A1KDM4EKMT2ANPSR1GFER
SCHEMBL1884436 0.80 ALDH1A1 (0.51) ALDH1A1KDM4EKMT2ANPSR1GFER
SCHEMBL28787262 0.79 TERT (0.60) ALDH1A1KDM4EKMT2ANPSR1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100076021-A1 Organic Compounds IMASE HIDETOMO 2010-03-25 US disclosed
US-20100076021-A1 Organic Compounds IMASE HIDETOMO 2010-03-25 US disclosed
US-20100076021-A1 Organic Compounds IMASE HIDETOMO 2010-03-25 US disclosed
EP-2084149-A1 ORGANIC COMPOUNDS Novartis AG (CH) 2009-08-05 EP disclosed
WO-2008058967-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2008-05-22 WO disclosed
WO-2008058967-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2008-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076021-A1 Organic Compounds CETP, NPC1, LCAT ALDH1A1 1522/4885KDM4E 2894/4885KMT2A 3521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.